Inhibin α and ß expression in ovarian stromal tumors and their histological equivalences

Acta Obstetricia et Gynecologica Scandinavica

Volumn 83, Issue 5, 2004, Pages 491-496

  Çiriş, Metin ^a   Erhan, Yildiz ^a   Zekioglu, Osman ^a   Bayramoglu, Hatice ^b  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Zekai Tahir Burak Women Hospital   (Turkey)

Author keywords

Immunohistochemistry; Inhibin; Ovarian tumors; Sex cord stromal tumors

Indexed keywords

INHIBIN A; INHIBIN B; PARAFFIN; TUMOR MARKER; INHIBIN; INHIBIN ALPHA SUBUNIT; INHIBIN-ALPHA SUBUNIT;

ADENOMYOSIS; ARTICLE; BURKITT LYMPHOMA; CANCER DIAGNOSIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DYSGERMINOMA; EPITHELIUM TUMOR; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; CASE CONTROL STUDY; ENDOMETRIAL STROMAL TUMOR; EVALUATION; METABOLISM; PREDICTION AND FORECASTING;

CASE-CONTROL STUDIES; ENDOMETRIAL STROMAL TUMORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBIN-BETA SUBUNITS; INHIBINS; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 2042508375     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2004.00167.x     Document Type: Article

References (31)

1. Koonings PP, Campbell K, Mishell DR, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10 year review. Obstet Gynecol 1989; 74: 921-6.
2. Fox H. Sex cord-stromal tumors of the ovary. J Pathol 1985; 145: 127-48.
3. Roth LM, Liban E, Czernobilsky B. Ovarian endometrioid tumors mimicking Sertoli and Sertoli-Leydig cell tumors. Cancer 1982; 50: 1322-31.
4. Tornos C, Silva EG, Ordonez NG, Gershenson DM, Young RH, Scully RE. Endometrioid carcinoma of the ovary with a prominent spindle-cell component, a source of diagnostic confusion. Am J Surg Pathol 1995; 19: 1343-53.
5. Stewart CJR, Jeffers MD, Kennedy A. Diagnostic value of inhibin immunreactivity in ovarian gonadal stromal tumors and their histological mimics. Histopathology 1997; 31: 67-74.
6. Blaustein A. Pathology of the female genital tract. 4th ed. New York: Springer-Verlag, 1994: 705-42.
7. Guerrieri C, Franlund B, Malmström H, Boeryd B. Ovarian endometrioid carcinomas simulating sex cord-stromal tumors: a study using inhibin and cytokeratin 7. Int J Gynecol Pathol 1998; 17: 266-71.
8. Flemming P, Wellmann A, Maschek H, Lang H, Georgii A. Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even their metastases. Am J Surg Pathol 1995; 19: 927-33.
9. Young RH, Prat J, Scully RE. Endometrioid stromal sarcomas of the ovary. A clinicopathologjc analysis of 23 cases. Cancer 1984; 53: 1143-55.
10. Bjorkholm E. Granulosa cell tumors: a comparison of survival in patients and matched controls. Am J Obstet 1980; 138: 329-31.
11. Bjorkholm E, Silfversward C. Prognostic factors in granulosa cell tumors. Gynecol Oncol 1981; 11: 261.
12. Costa MJ, DeRose PB, Roth LM, Brescia RJ, Zaloudek CJ, Cohen C. Immunohistochemical phenotype of ovarian granulosa cell tumors: absence of epithelial membrane antigen has diagnostic value. Hum Pathol 1994; 25: 60-6.
13. Otis CN, Powell JL, Barbuto D, Carcangiu ML. Intermediate flamentous proteins in adult granulosa cell tumors. An immunohistochemical study of 25 cases. Am J Surg Pathol 1992; 16: 962-8.
14. Shaw JA, Dabbs DJ, Geisinger KR. Sclerosing stromal tumor of the ovary: an ultrastructural and immunohistochemical analysis with histogenetic considerations. Ultrastruct Pathol 1992; 16: 363-77.
15. Gurusinghe CJ, Healy DL, Jobling T, Mamers P, Burger HG. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol Oncol 1995; 57: 27-32.
16. Flemming P, Grothe W, Maschek H, Petry KU, Wellmann A, Georgii A. The site of inhibin production in ovarian neoplasms. Histopathology 1996; 29: 465-8.
17. McClugage WG. Value of inhibin staining in gynecological pathology. Int J Gynecol Pathol 2001; 20: 79-85.
18. Yaziji H, Gown AM. Immunohistochemical analysis of gynecologic tumors. Int J Gynecol Pathol 2001; 20: 64-78.
19. Wallace EM, Healy DL. Inhibins and activins: roles in clinical practice. Br J Obstet Gynecol 1996; 103: 945-56.
20. McLachlan RI, Robertson DM, DeKretser DM, Burger HG. Advances in the physiology of inhibin and inhibin-related peptides. Clin Endocrinol 1988; 29: 77-114.
21. Zheng W, Sung CJ, Hanna I, De Petris G, Lambert-Messerlion G, Steinhoff N et al. α and β subunits of inhibin/activin as sex cord-stromal differentiation markers. Int J Gynecol Pathol 1997; 16: 263-71.
22. Rishi M, Howard LN, Bratthauer GL, Tavassoli FA. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 1997; 21: 583-9.
23. Scully RE. Small cell carcinoma of hypercalcemic type. Int J Gynecol Pathol 1993; 12: 148-52.
24. Loo KT, Leung AKF, Chan JKC. Immunohistochemical staining of ovarian granulosa cell tumors with MIC2 antibody. Histopathology 1995; 27: 388-90.
25. Gordon MD, Corless C, Renshaw AA, Beckstead J. CD99, keratin and vimentin staining of sex cord-stromal tumors, normal ovary and testis. Mod Pathol 1998; 11: 769-73.
26. Matias-Guiu X, Pons C, Prat J. Mullerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Human Pathol 1998; 29: 840-5.
27. McCluggage WG, Paxwell P. Adenocarcinomas of various sites may exhibit immunreactivity with anti-inhibin antibodies. Histopathology 1999; 35: 216-20.
28. Cooke I, O'Brien MO, Charnock FM, Groome N, Ganesan TS. Inhibin as a marker for ovarian cancer. Br J Cancer 1995; 71: 1046-50.
29. Lappohn RE, Burger HG, Bouma J, Bangah M, Krans M, de Bruijn HWA. Inhibin as a marker for granulosa-cell tumors. N Engl J Med 1989; 321: 790-1.
30. Robertson DM, Stephenson T, Pruysers E, McCloud P, Tsigos A, Groome N et al. Characterization of inhibin forms and their measurement by an inhibin alpha- subunit ELISA in serum from postmenopausal women with ovarian cancer. J Clin Endocrinol Metab 2002; 87: 816-24.
31. Yamashita K, Yamuto M, Shikone T, Minami S, Nakano R. Immunohistochemical localization of inhibin and activin subunits in human epithelial ovarian tumors. Am J Obstet Gynecol 1999; 180: 316-22.